F1SCHEDULE5Monitoring for indicative dose and analytical performance characteristics

Annotations:
Amendments (Textual)

Monitoring for compliance with the indicative doseF12

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .